	US 12,239,727 B2
	Compositions for use in the treatment of photosensitivity
Lars Otto Uttenthal, Madrid (ES); and Torsten Bjørn, Kvistgård (DK)
Assigned to RepoCeuticals A/S, Hørsholm (DK)
Appl. No. 17/296,874
Filed by RepoCeuticals A/S, Hørsholm (DK)
PCT Filed Dec. 4, 2019, PCT No. PCT/EP2019/083610 § 371(c)(1), (2) Date May 25, 2021, PCT Pub. No. WO2020/115102, PCT Pub. Date Jun. 11, 2020.
Claims priority of application No. PA 2018 70796 (DK), filed on Dec. 5, 2018; and application No. PA 2019 70031 (DK), filed on Jan. 16, 2019.
Prior Publication US 2022/0016006 A1, Jan. 20, 2022
Int. Cl. A61K 8/49 (2006.01); A61K 8/46 (2006.01); A61Q 17/04 (2006.01)

CPC A61K 8/492 (2013.01) [A61K 8/46 (2013.01); A61Q 17/04 (2013.01)]

8 Claims

1. A method of treating skin photosensitivity of a subject in need thereof comprising topically administering to said subject a composition comprising

melatonin

and

dimethyl sulfoxide (DMSO).